A study of the safety and efficacy of MB-dNPM-1-TCR.1 in patients with relapsed or refractory AML.

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-505806-41-00

Acronym

M-2020-358

Enrollment

Registered

2023-12-18

Start date

2024-08-01

Completion date

Unknown

Last updated

2025-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myeloid leukemia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026